Baird Medical News – Page 5 – Baird Medical Official

Oct 22, 2024

Baird Honored to Attend ACS 2024

San Francisco, October 18-22, 2024 – Baird Medical was proud to be invited to showcase its cutting-edge microwave ablation (MWA) technology at the renowned American College of Surgeons (ACS) Clinical Congress, held at the Moscone Center in San Francisco. As...

Oct 12, 2024

Baird Medical's First MWA Training Day in the U.S.

Octotber 12 2024 - We are thrilled to share insights from our first Microwave Ablation (MWA) training session in the U.S., led by Dr. Emad Kandil from Tulane University, in collaboration with Dr. Terry Lairmore, an esteemed endocrine surgeon from...

Oct 10, 2024

Dr. Alireza Falahati Explores MWA Techniques in China

October 2024 — Dr. Alireza Falahati, a leading endocrinologist and Founder of Utah Endocrinology Associates, began the first day of his academic exchange at Sun Yat-sen University Cancer Center’s Ultrasound Department in Guangzhou, China. The visit included observing three live...

Oct 03, 2024

Baird Medical Celebrates Listing on NASDAQ

Baird Medical successfully listed on NASDAQ, marking a major milestone in its growth as a global leader in microwave ablation technology. This listing enhances Baird Medical’s visibility in the international healthcare market, supporting the company’s mission to advance minimally invasive treatment options for patients worldwide.

Oct 03, 2024

Medical Case Study: Microwave Ablation (MWA) Outperforms Radiofrequency Ablation (RFA) in the Treatment of Thyroid Nodules

Microwave Ablation (MWA) has emerged as a superior alternative to Radiofrequency Ablation (RFA) for the treatment of thyroid nodules, particularly in cases involving highly vascular tissue. This case study presents a comparative analysis of both techniques, highlighting MWA’s advantages in...